Hepatocellular carcinoma
Conditions
Interventions
Therapy group (TACE/HAIC+immunotherapy+targeted therapy):None
Sponsors
Harbin Medical University Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: ? Age: 18 to 75 years old, regardless of gender; ? BCLC stage B or C, hepatocellular carcinoma that cannot be radically resected; ? Child-Pugh score A or B; ? ECOG PS score: 0-1 points; ? According to the modified response evaluation criteria in solid tumors (mRECIST), there is at least one evaluable target lesion; ? Treatment compliance is good, and there are no serious diseases in other important organs. ? Those with complete clinical data and complete follow-up information, and clinical review on time
Exclusion criteria
Exclusion criteria: ? Pregnant or lactating women; ? Combined with other primary malignant tumors; ? Receive other anti-tumor treatments during the course of the disease; ? Liver function Child-Pugh classification grade C; ? The data is incomplete; ? Patient refuses follow-up or is unable to follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease control rate;Progression free survival;Overall survival;Safety; | — |
Countries
China
Contacts
Public ContactYan Liu
Harbin Medical University Cancer Hospital
Outcome results
None listed